Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer
- Conditions
- Bladder Cancer Recurrence
- Registration Number
- NCT00903240
- Lead Sponsor
- Predictive Biosciences
- Brief Summary
The purpose of this study is to detect recurrent bladder cancer using a combination of protein and DNA biomarkers in urine
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1000
- Intact bladder
- Scheduled for cystoscopy for transitional cell bladder cancer recurrence screening
- Urine donated prior to cystoscopy, Bladder biopsy, chemotherapy, intravesical therapy, radiation or TUR
- Must be willing to sign IRB approved informed consent
- History or current diagnosis of any cancer except transitional cell bladder cancer or basal cell cancer
- Known diagnosis of any autoimmune disease or HIV, HCV or HBV
- History or current TB or any other active infection
- Subject has gross hematuria
- Receiving chemotherapy, intravesical therapy or radiation within 30 days of enrollment
- Any surgery except urologic within past 30 days
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (20)
Urology Associates
๐บ๐ธEngelwood, Colorado, United States
Winter Park Urology
๐บ๐ธOrlando, Florida, United States
Atlantic Urological Associates
๐บ๐ธDaytona Beach, Florida, United States
Metropolitan Urology
๐บ๐ธJeffersonville, Indiana, United States
Associates in Urology/Urology Group of NJ
๐บ๐ธ741 Northfield Avenue, New Jersey, United States
Coastal Urology Associates
๐บ๐ธBrick, New Jersey, United States
Metro Urology
๐บ๐ธWoodbury, Minnesota, United States
Capital Regional Urological Surgeons
๐บ๐ธAlbany, New York, United States
Community Care Physicians
๐บ๐ธAlbany, New York, United States
Associated Medical Professionals
๐บ๐ธSyracuse, New York, United States
University Urology Associates
๐บ๐ธNew York, New York, United States
Hudson Valley Urology
๐บ๐ธPoughkeepsie, New York, United States
Urological Associates of Lancaster
๐บ๐ธLancaster, Pennsylvania, United States
Triangle Urologic Group
๐บ๐ธPittsburgh, Pennsylvania, United States
Carolina Urologic Research Center
๐บ๐ธMyrtle Beach, South Carolina, United States
Urology Clinics of North Texas
๐บ๐ธDallas, Texas, United States
BCG Oncology
๐บ๐ธPhoenix, Arizona, United States
Mayo Validation Support Services
๐บ๐ธRochester, Minnesota, United States
Urology San Antonio Research
๐บ๐ธSan Antonio, Texas, United States
The Urology Group
๐บ๐ธCincinnati, Ohio, United States